Market news

Elevance Health has delivered a 1 year gain that puts the stock firmly on investors' radar, and the latest reaffirmed earnings outlook has only sharpened the focus on what you are paying for each dollar of profit. With the price around US$410.95 at the last close, the key issue now is whether that tag lines up with the insurer's earnings power. The stock is up 33.6% over the past year, which raises the question of whether that move is grounded in its underlying earnings profile. Management...

Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.

Detailed price information for Elevance Health Inc (ELV-N) from The Globe and Mail including charting and trades.

UBS benefits survey ranks Elevance top insurer as 77% of employers rebid 2027 plans; GLP-1 costs surge and big PBMs stay strong—read now.

Key Takeaways:Guidance Raised: Elevance Health lifted 2026 adjusted EPS guidance to at least $27, up from prior levels, after a strong Q2. Price Projection: Based on current execution, ELV stock could reach $494 by December 2028.

Detailed price information for Elevance Health Inc (ELV-N) from The Globe and Mail including charting and trades.

Elevance Health Inc (NYSE:ELV) recently announced a total dividend of $1.72 per share, with the ex-dividend date set for 2026-09-10. For investors, the ex-dividend date is a critical marker: shareholders must own the stock before this date to qualify for the upcoming payment. As investors look forward to this next distribution, the spotlight also shines on the company's dividend history, yield, and growth rates.

Detailed price information for Elevance Health Inc (ELV-N) from The Globe and Mail including charting and trades.

First Eagle Investment Management, an investment management company, released its Q2 2026 investor update for “First Eagle Global Fund”. The letter can be downloaded here. Easing tensions in the Middle East led to a strong rally in risk markets in Q2. The S&P 500 Index rose 15.2%, while the MSCI EAFE Index gained 10.8%. Growth […]

Hotchkis & Wiley, an investment management company, released its second-quarter 2026 investor letter for the “Large Cap Fundamental Value Fund.” A copy can be downloaded here. Equity markets posted strong returns, with the Russell 1000 Value Index rising by 13.9%, although many individual stocks lagged. Notably, semiconductor stocks and AI-related sectors saw exceptional gains. The rally […]

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance providers stocks fared in Q2, starting with Elevance Health (NYSE:ELV).

In recent weeks, Elevance Health has been highlighted for strong Q2 2026 results, raised full-year guidance, and operational gains driven by AI-enabled efficiency and cost savings. At the same time, the appointment of Dr. Patrick Fox to lead Carelon Behavioral Services underscores Elevance Health’s emphasis on behavioral health capabilities within its broader health services platform. Next, we’ll examine how Elevance’s AI-driven margin improvements and refreshed behavioral health leadership...

Elevance Health (ELV) drew fresh attention this week after its Carelon Behavioral Health unit appointed forensic psychiatrist Dr. Patrick Fox as leader, putting behavioral services for more than 61 million members under new oversight. Those leadership changes come as Elevance Health trades at US$398.87, with a 30 day share price return of 5.61% and year to date share price return of 12.60%. The 1 year total shareholder return of 31.36% contrasts with a 3 year total shareholder return that is...

Sound Shore Management, an investment management firm, has released its investor letter for the second quarter of 2026. The letter can be downloaded here. The Sound Shore Fund’s Investor Class (SSHFX) and Institutional Class (SSHVX) rose 10.48% and 10.58% in the second quarter of 2026, trailing the Russell 1000 Value Index’s 13.87% and the S&P […]

Dr. Patrick Fox, a forensic psychiatrist and health plan leader, will take the reins at Carelon Behavioral Services effective immediately. His experience will be “invaluable” for the unit, a top Elevance executive said.

Despite Elevance Health's outperformance relative to the broader market over the past 52 weeks, Wall Street analysts remain cautiously optimistic about the stock's prospects.

Highlighted by clinical facility expansion from Acadia Healthcare and Universal Health Services (UHS), payer integration via Elevance Health (Carelon Behavioral Health), and digital therapy platform growth across BetterHelp (Teladoc Health), Talkspace, Calm, Lyra Health, and Spring Health, the industry is undergoing structural transformation. This study delivers a comprehensive evaluation of 24,696 mental health facilities operated by 14,554 companies, outpatient ($38.2 billion) versus inpatient

Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Elevance Health has delivered a 37.6% gain over the past year, yet current valuation checks still lean on the side of the stock looking inexpensive rather than stretched. For investors, that creates a pricing debate around how much of the company’s recent health data partnerships and care model initiatives is already reflected in today’s US$398.22 share price. Over the last 12 months Elevance Health is up 37.6%. This puts recent shareholders in a comfortable spot and raises the bar for what...

Greenskeeper Asset Management, an independent firm that specializes in disciplined value investing, recently released its Q2 2026 scorecard. A copy is available to download here. After a slow start to the year, the Fund gained 10.9% in the quarter, lifting its year-to-date return to 1.9%. The rebound came as markets showed signs of rotating away from momentum […]

Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here. The Fund gained 11.99% during the quarter, compared with the 10.48% gain for the Russell 3000 Health Care Index and the 15.44% gain for the Russell 3000 Index. Since inception, […]

Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its “Large Cap Strategy”. A copy of the letter is available to download here. The Strategy returned 3.42% net of fees, trailing the Russell 1000 Value Index’s 13.87% gain. Performance benefited from stock selection in consumer staples, materials and consumer discretionary, along with an underweight in utilities. However, stock […]

Elevance Health (ELV) recently highlighted an expanded connected cancer care model that uses predictive analytics and dedicated oncology support to coordinate treatment, reduce avoidable complications, and provide more personalized resources across patients’ entire care journeys. See our latest analysis for Elevance Health. Against this backdrop, Elevance Health’s share price is US$375.84, with a year to date share price return of 6.09%. The 1 month share price return is down 9.70%, although...

Gail Boudreaux credits collegiate athletics with helping to shape her leadership style.

Investment management company Vulcan Value Partners recently released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. Vulcan Value Partners prioritizes long-term returns and lower risk over short-term performance. In the quarter, the Large Cap Composite (Net) returned 9.5%, the Small Cap Composite (Net) returned 13.3%, the Focus Composite (Net) returned 10.4%, the […]